Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder that is characterized by a t (9; 22) translocation, which results in the expression of BCR-ABL fusion oncoproteins that are unique to the leukemic cells. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.